Vanessa is joining as General Manager she is heading the new company. Can't blame her leaving for career progression. It must mean that the experience at Prima Biomed is highly regarded.
I am happy that you posted this important information. And I don't agree with those who infer that you wanted to dampen the reversal, by suggesting that Vanessa is leaving because she knows that the Phase 2b results are not good.
Many questions for you. 1.Do you expect to buy and when. 2. Can you tell me when to offload some during the next run. 3. Why is PRR not listed in the article you mentioned.
Thanks Brainy
PRR Price at posting:
9.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)